Evidence map›Paper›PMID 39628314›Full record

ArticleACS infectious diseases2024

Joshua D Shirley, Jacob R Gillingham, Kelsie M Nauta, Shivani Diwakar, Erin E Carlson

Abstract read
In one paragraph

Article in ACS infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

  • Update of
    2024
5 · Who and what money

Authors and funding

5 authors.

Joshua D ShirleyDepartment of Medicinal Chemistry, University of Minnesota, 208 Harvard Street SE, Minneapolis, Minnesota 55454, United States.
Jacob R GillinghamDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, 321 Church St SE, Minneapolis, Minnesota 55454, United States.ORCID 0000-0002-6717-9960
Kelsie M NautaDepartment of Chemistry, University of Minnesota, 207 Pleasant Street SE, Minneapolis, Minnesota 55455, United States.
Shivani DiwakarDepartment of Pharmacology, University of Minnesota, 321 Church St SE, Minneapolis, Minnesota 55454, United States.
Erin E CarlsonDepartment of Medicinal Chemistry, University of Minnesota, 208 Harvard Street SE, Minneapolis, Minnesota 55454, United States.ORCID 0000-0001-8287-8893

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
NRSA Training CoreTL1TR002493 · NCATS · UNIVERSITY OF MINNESOTA · PI FULKERSON, JAYNE ALLYN · 2018 to 2022
$3.1M
Training the Next Generation of Chemical BiologistsT32GM132029 · NIGMS · UNIVERSITY OF MINNESOTA · PI Erin Elizabeth Carlson, William Charles Krause Pomerantz · 2019 to 2026
$2.7M
Chemical Strategies to Map Bacterial Response to Environmental ChangeR35GM153306 · NIGMS · UNIVERSITY OF MINNESOTA · PI Erin Elizabeth Carlson · 2024 to 2026
$1.6M
Chemical Methods to Characterize Penicillin-Binding Protein Function and InteractionsR01GM140486 · NIGMS · UNIVERSITY OF MINNESOTA · PI CARLSON, ERIN ELIZABETH · 2020 to 2023
$1.2M
Spaciotemporal Regulation of Specific Penicillin Binding Protein (PBP) Function Determined by New Activity-Based ApproachesR01GM128439 · NIGMS · UNIVERSITY OF MINNESOTA · PI CARLSON, ERIN ELIZABETH, WINKLER, MALCOLM E. · 2018 to 2019
$936k
NCATS NIH HHS TL1 TR002493NCATS NIH HHS UL1 TR002494NIGMS NIH HHS R01 GM128439NIGMS NIH HHS R01 GM140486NIGMS NIH HHS R35 GM153306NIGMS NIH HHS T32 GM132029
6 · The paper itself

Abstract

Penicillin-binding proteins (PBPs) are an essential family of bacterial enzymes that are covalently inhibited by the β-lactam class of antibiotics. PBP inhibition disrupts peptidoglycan biosynthesis, which results in deficient growth and proliferation, and ultimately leads to lysis. IC

Indexed as

Anti-Bacterial AgentsPenicillin-Binding ProteinsStreptococcus pneumoniaebeta-LactamsBoron CompoundsKineticsMicrobial Sensitivity TestsPenicillinsAnti-Bacterial Agentsbeta-LactamsBOCILLIN FLBoron CompoundsPenicillin-Binding ProteinsPenicillinscovalent inhibitionkinact/KIlive-cell assaypenicillin-binding proteinsStreptococcus pneumoniaestructure−activity relationship

Identifiers

PMID39628314
PMCPMC11984511

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.